The involvement of P-glycoprotein in berberine absorption

Pharmacology and Toxicology

Volumn 91, Issue 4, 2002, Pages 193-197

  Pan, Guo Yu ^b   Wang, Guang Ji ^a   Liu, Xiao Dong ^b   Fawcett, J Paul ^b   Xie, Yuan Yuan ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; CHINESE DRUG; CYCLOSPORIN A; GLYCOPROTEIN P; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY C219; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG PROTEIN BINDING; INHIBITION KINETICS; INTESTINE ABSORPTION; INTESTINE MUCOSA; INTESTINE PERFUSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROSA; TRADITIONAL MEDICINE;

ANIMALS; BERBERINE; CACO-2 CELLS; CELLS, CULTURED; CYCLOSPORINE; HUMANS; INTESTINAL ABSORPTION; P-GLYCOPROTEIN; RATS; VERAPAMIL;

ANIMALIA; CANIS FAMILIARIS;

EID: 0036797498     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2002.t01-1-910403.x     Document Type: Article

References (24)

1. Asperen, J. V., O. H. Van Telligen & J. H. Beijnen: The pharmacological role of P-glycoprotein in the intestinal epithelium. Pharmacol. Res. 1998, 37, 429-435.
2. Batrakova, E. V., H. Y. Han, V. Y. Alakhov, D. W. Miller & A. V. Kabano: Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers. Pharm. Res. 1998, 15, 850-855.
3. Benet, L. Z., T. Izumi, Y. Zhang, J. A. Silverman & V. J. Wacher: Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery. J. Control. Release. 1999, 62, 25-31.
4. Chung, J. G., G. W. Chen, C. F. Hung, et al.: Effects of berberine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adduct formation in human leukemia cells. Am. J. Chin. Med. 2000, 28, 227-238.
5. Cormet-Boyaka, E., J. F. Huneau, A. Mordrelle, et al.: Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors. Antimicrob. Agents Chemother. 1998, 42, 2607-2611
6. Elias, G., J. T. Zhang & V. Ling: Modulation of ATP and drug binding by monoclonal antibodies against P-glycoprotein. J. Cell. Physiol. 1991, 148, 479-484.
7. He, L. & G. Q. Liu: Effects of various principles on rhodamine 123 accumulation in brain capillary endothelial cells. Acta Pharmacol. Sinica 2002, 23, (in press).
8. Hiroshi, S. & B. J. Aungst: Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine. Pharm. Res. 1995, 12, 1304-1310.
9. Hunter, J. & B. H. Hirst: Intestinal secretion of drugs: The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption. Adv. Drug Deliv. Rev. 1997, 25, 129-157.
10. Ikumi, T., A. Saheki, R. Saitoh, et al.: Nonlinear intestinal absorption of 5-hydroxytryptamine receptor antagonist caused by absorptive and secretory transporters. J. Pharmacol. Exp. Therap. 1997, 283, 108-115.
11. Li, Q., X. C. Wu, N. H. Xin, et al.: Clinical study on coadministration of cyclosporin A and berberine hydrochloride in renal transplanted recipients. China J. Clin. Pharmacol. 2001, 17, 114-117.
12. Lin, H. L., T. Y. Liu, C. W. Wu & C. W. Chi: Berberine modulates expression of mdr1 gene product and the respones of digestive tract cancer cells to Paclitaxel. Brit. J. Cancer 1999, 81, 416-422.
13. Liu, J. C., P. Chan, Y. J. Chen, et al.: The antihypertensive effect of the berberine derivative 6-protoberberine in spontaneously hypertensive rats. Pharmacology 1999, 59, 283-289.
14. Lo, Y. L. & J. D. Huang: Effects of sodium deoxycholate and sodium caproate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats. Biochem. Pharmacol. 2000, 59, 665-672.
15. Misaki, T., K. Sagara, M. Ojima, et al.: Simultaneous determination of berberine, palmatine and coptisine in crude drugs and oriental pharmaceutical preparations by ion-pair high-performance liquid chromatography. Chem. Pharm. Bull. 1982, 30, 354-357.
16. Palm, K. K. Luthman, A. L. Ungell, et al.: Correlation of drug absorption with molecular surface properties. J. Pharmaceutical Sci. 1996, 85, 32-39.
17. Prueksaritanont, T., P. Deluna, L. M. Gorham, et al.: In vitro and in vivo evaluations of intestinal barriers for the zwitterion L-767,679 and its carboxyl ester prodrug L-775,318. Drug Metab. Dis. 1998, 26, 520-527.
18. Shen, Z. F. & M. Z. Xie: Determination of berberine in biological specimens by high performance TLC and fluoro-densitometric method. Acta Pharm. Sin. 1993, 28, 532-536.
19. Sheng, M. P., Q. Sun & H. Wang: Studies on the intravenous pharmacokinetics and oral absorption of berberine HCl in beagle dogs. Sin. Pharmacol. Bull. 1993, 9, 64-67.
20. Stermitz, F. R., P. Lorenz, J. N. Tawara, L. A. Zenewicz & K. Lewis. Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5′-methoxyhydrocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 1433-1437.
21. Stewart, B. H., O. H. Chan, N. Jezyk, et al.: Discrimination between drug candidates using models for evaluation of intestinal absorption. Adv. Drug Deliv. Rev. 1997, 23: 27-45.
22. Taylor, C. T., D. C. Winter, M. M. Skelly, et al.: Berberine inhibits ion transport in human colonic epithelia. Eur. J. Pharmacol. 1999, 368, 111-118.
23. Yumoto, R., T. Murakami, Y. Nakamoto, et al.: Transport of Rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds. J. Pharmacol. Exp. Therap. 1999, 289, 149-155.
24. Zhou, H. & S. Mineshita: The effect of berberine chloride on experimental colitis in rats in vivo and in vitro. J. Pharmacol. Exp. Therap. 2000, 294, 822-829.